Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

TT Electronics Launches Compact TAAM700 Medical Grade Power Supply

TT Electronics, a global provider of engineered technologies for performance critical applications, today announced the launch of its new 700 watt medical-grade enclosed power supply, the TAAM700. With a small 6.7 inch x 3.66inch footprint, the TAAM700 provides 17.8W per cubic inch and a wide operating temperature range from ‐30°C to +70°C forthermally challenged environments. Coupled with its compact size, TAAM700’s industry leading power density is ideal for space-constrained healthcare and industrial equipment, such as laser devices and robotics.

“The TAAM700 is an important addition to our already extensive medical power supply portfolio, offering 700 watt performance contrasted to the 650 watts available from other manufacturers,” said Frank Rene, general manager, power/IoT solutions, TT Electronics. “Where space is at a premium and high efficiency and safety/EMC compliance is critical, medical and industrial OEMs have a smarter option for industry leading power density and optimized footprint.”

This highly efficient and cost effective power supply provides 625-700 watts of continuous output power with a remote ON/OFF function, optional built‐in current share (configurable to 1.26kW) and features BF rated outputs. The TAAM700 is approved to UL/EN/IEC 60601-1. All models meet FCC PART 15 and EN55032 class B emission limits, and comply with UL, IEC, CE, UKCA and more.

The TAAM700 offers standard output voltages from 12VDC to 48VDC. All options are fully certified to applicable safety and EMC standards, reducing compliance risk, simplifying design-in, and accelerating time to market for end system designs.

View information on the TAAM700 here.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy